Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes., PMID:33653890
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection., PMID:32716975
Utility of HSV Serology for Chronic Corneal Pathology., PMID:31306215
The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects., PMID:28448558
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific., PMID:26109729
Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans., PMID:25142599
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006., PMID:22085620
Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone., PMID:21813597
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies., PMID:20171247
Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN., PMID:18796707
Impact of a community sexually transmitted infection/HIV intervention project on female sex workers in five border provinces of Vietnam., PMID:17327262
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody., PMID:16571820
Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential., PMID:15695655
CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals., PMID:15269352
Characterization of B virus glycoprotein antibodies induced by DNA immunization., PMID:12417944
Differentiation of Herpes simplex virus types 1 and 2 in sera of patients with HSV central nervous system infections by type-specific enzyme-linked immunosorbent assay., PMID:11798261
Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C., PMID:10580201
3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses., PMID:9875389
Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM)., PMID:9814873
Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies., PMID:9661836
Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture., PMID:9652417
Expression and Purification of Secreted Forms of HSV Glycoproteins from Baculovirus-Infected Insect Cells., PMID:21374226
Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection., PMID:9199708
Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes., PMID:7829255
An evaluation of a hemagglutination-inhibition test for the detection of antibodies to herpes simplex virus type 1., PMID:15566801
Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections., PMID:8014499
[Biological properties of hemagglutinin of herpes simplex virus type 1]., PMID:8175105
A rapid simple in situ hybridization method for herpes simplex virus employing a synthetic biotin-labeled oligonucleotide probe: a comparison with immunohistochemical methods for HSV detection., PMID:8189321
Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein., PMID:8406590
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C., PMID:1378512
Structural basis of C3b binding by glycoprotein C of herpes simplex virus., PMID:1602532
Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement., PMID:1333754
A related epitope is consistently present on glycoprotein C of herpes simplex virus type 1 and 2., PMID:1719785
Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2., PMID:1681713
Inducible expression of herpes simplex virus type 1 glycoprotein C in NIH 3T3 cells., PMID:1965287
Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C., PMID:2164613
Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor., PMID:2154609
Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins., PMID:2848900
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2., PMID:2845122
Induction of Fc and C3b receptors on rabbit corneal cells by herpes simplex virus., PMID:3417420
Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins., PMID:2835427
Zwitterionic detergent solubilisation of HSV-1 surface antigens., PMID:2831853
Typing of herpes simplex virus types 1 and 2 by immunoblotting analysis using polyclonal antisera to herpes simplex virus glycoproteins., PMID:2828400
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity., PMID:2824652
Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus., PMID:3029407
Detection of asymptomatic herpes simplex virus infections after vaccination., PMID:3806788
Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates., PMID:3021981
Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment., PMID:3020821
Expression of herpes simplex virus glycoproteins in polarized epithelial cells., PMID:3009881
For research use only. Not for human or drug use.
